Author:
Waśkiel-Burnat Anna,Rudnicka Lidia
Publisher
Springer International Publishing
Reference26 articles.
1. Arif T, Dorjay K, Adil M, Sami M. Dutasteride in androgenetic alopecia: an update. Curr Clin Pharmacol. 2017;12(1):31–5. https://doi.org/10.2174/1574884712666170310111125.
2. Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen effluvium: a review of the literature. Cureus. 2020;12(5):e8320. https://doi.org/10.7759/cureus.8320.
3. Blume-Peytavi U, Shapiro J, Messenger AG, Hordinsky MK, Zhang P, Quiza C, Doshi U, Olsen EA. Efficacy and safety of once-daily minoxidil foam 5% versus twice-daily minoxidil solution 2% in female pattern hair loss: a phase III, randomized, investigator-blinded study. J Drugs Dermatol. 2016;15(7):883–9.
4. Brzezińska-Wcisło L, Rakowska A, Rudnicka L, Bergler-Czop B, Czuwara J, Maj J, Olszewska M, Placek W, Reich A, Zegarska B. Łysienie androgenowe kobiet i mężczyzn. Rekomendacje diagnostyczno-terapeutyczne Polskiego Towarzystwa Dermatologicznego. Dermatol Rev. 2018;105(1):1–18. https://doi.org/10.5114/dr.2018.74162.
5. Firooz A, Rajabi-Estarabadi A, Zartab H, Hassanzadeh H, Dowlati Y. Classification and scoring of androgenetic alopecia (male and female pattern). In: Humbert P, Fanian F, Maibach HI, Agache P, editors. Agache’s measuring the skin: non-invasive investigations, physiology, normal constants. Cham: Springer; 2017. p. 1437–42. https://doi.org/10.1007/978-3-319-32383-1_101.